Fecal microbiota transplantation (FMT) has changed the treatment landscape of Clostridium
difficile infection (CDI). Emerging evidence has shown that FMT can also be an effective and …

Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium
difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT …

The gut bacterial microbiome, particularly its role in disease and inflammation, has gained
international attention with the successful use of fecal microbiota transplantation (FMT) in the …

Fecal microbiota transplantation (FMT) has successfully been applied for the treatment of
recurrent Clostridioides difficile infection (CDI), which has led to studies on its application to …

Inflammatory bowel disease (IBD) is a chronic multifactorial disease that affects the
gastrointestinal tract and results from an aberrant immune response toward luminal antigens …

Faecal microbiota transplant (FMT) has now been established into clinical guidelines for the
treatment of recurrent and refractory Clostridioides difficile infection (CDI). Its therapeutic …

Fecal microbiota transplantation (FMT) has evolved from a case report in the medical
literature to the basis of major innovations in the treatment of Clostridium difficile infection …

Background New treatments are needed as Clostridium difficile infection (CDI) is becoming
increasingly formidable. Fecal microbiota transplantation (FMT) has a 90% success rate in …

Fecal microbiota transplantation (FMT) is considered to be a highly successful therapy for
recurrent and refractory Clostridium difficile infection (CDI) based on recent clinical trials …

Fecal microbiota transplantation (FMT) represents the most effective means of
therapeutically manipulating the gastrointestinal microbiome. Originally employed as a …